Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy

Brain

Volumn 119, Issue 3, 1996, Pages 775-787

  Gabriel, J M ^a   Erne, B ^a   Miescher, G C ^a   Miller, S L ^b   Vital, A ^c   Vital, C ^c   Steck, A J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Children's Hospital   (United States)

^c HÔPITAL PELLEGRIN   (France)

Author keywords

Anti MAG autoantibodies; Enzyme immunohistochemistry; Myelin associated glycoprotein; Paraproteinaemic polyneuropathy; Quantitative image analysis

Indexed keywords

AUTOANTIBODY; CARBOHYDRATE; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; PERIAXIN; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DEMYELINATING NEUROPATHY; DEMYELINATING PARAPROTEINAEMIC POLYNEUROPATHY; DEMYELINATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; MYELINATED NERVE; NERVE BIOPSY; PARAPROTEINEMIA; PRIORITY JOURNAL;

ANTIBODY SPECIFICITY; ANTIGENS, CD57; AUTOANTIBODIES; BIOLOGICAL MARKERS; BIOPSY; DEMYELINATING DISEASES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; MALE; MYELIN PROTEINS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; PARAPROTEINEMIAS; PERIPHERAL NERVOUS SYSTEM DISEASES; PERONEAL NERVE; STAINING AND LABELING;

EID: 0029943955     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.3.775     Document Type: Article

References (44)

1. Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 1981; 127: 1024-9.
2. 0. J Neurosci Res 1993; 35: 46-53.
3. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993; 262: 2039-42.
4. Bianchini D, De Martini I, Cadoni A, Zicca A, Tabaton M, Schenone A, et al. GFAP expression of human Schwann cells in tissue culture. Brain Res 1992; 570: 209-17.
5. 0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy. Neurology 1988; 38: 1266-70.
6. Braun PE, Frail DE, Latov N. Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem 1982; 39: 1261-5.
7. Brouet JC, Mariette X, Chevalier A, Hauttecoeur B. Determination of the affinity of monoclonal human IgM for myelin-associated glycoprotein and sulfated glucuronic paragloboside. J Neuroimmunol 1992; 36: 209-15.
8. 0 and myelin-associated glycoprotein. J Neurochem 1990; 54: 1569-75.
9. Debus E, Weber K, Osborn M. Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides. Differentiation 1983; 25: 193-203.
10. Feinstein DL, Weinmaster GA, Milner RJ. Isolation of cDNA clones encoding rat glial fibrillary acidic protein: expression in astrocytes and in Schwann cells. J Neurosci Res 1992; 32: 1-14.
11. Frail DE, Edwards AM, Braun PE. Molecular characteristics of the epitope in myelin-associated glycoprotein that is recognized by a monoclonal IgM in human neuropathy patients. Mol Immunol 1984; 21: 721-5.
12. Fruttiger M, Montag D, Schachner M, Martini R. Crucial role for the Myelin-associated glycoprotein in the maintenance of axonmyelin integrity. Eur J Neurosci 1995; 7: 511-15.
13. Gillespie CS, Sherman DL, Blair GE, Brophy PJ. Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 1994; 12: 497-508.
14. Ilyas AA, Quarles RH, MacIntosh TD, Dobersen MJ, Trapp BD, Dalakas MC, et al. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelinassociated glycoprotein and to a ganglioside. Proc Natl Acad Sci USA 1984; 81: 1225-9.
15. Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994; 117: 941-7.
16. King RHM, Thomas PK. The occurrence and significance of myelin with unusually large periodicity. Acta Neuropathol (Berl) 1984; 63: 319-29.
17. Lach B, Rippstein P, Atack D, Afar DE, Gregor A. Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy. Acta Neuropathol (Berl) 1993; 85: 298-307.
18. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerly W, Trapp B, et al. Myelination in the absence of myelin-associated glycoprotein. Nature 1994; 369: 747-50.
19. Mancardi GL, Cadoni A, Tabaton M, Schenone A, Zicca A, De Martini I, et al. Schwann cell GFAP expression increases in axonal neuropathies. J Neurol Sci 1991; 102: 177-83.
20. Martini R. Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. [Review]. J Neurocytol 1994; 23: 1-28.
21. McGarry RC, Helfand SL, Quarles RH, Roder JC. Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature 1983; 306: 376-8.
22. Mendell JR, Sahenk Z, Whitaker JN, Trapp BD, Yates AJ, Griggs RC, et al. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody. Ann Neurol 1985; 17: 243-54.
23. Mezei C. Myelination in the peripheral nerve during development. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. 3rd ed. Philadelphia: W. B. Saunders, 1993: 267-81.
24. Miller SL, Pleasure D, Herlyn M, Atkinson B, Ernst C, Tachovsky TG, et al. Production and characterization of monoclonal antibodies to peripheral and central nervous system myelin. J Neurochem 1984; 43: 394-400.
25. Mokuno K, Kamholz J, Behrman T, Black C, Sessa M, Feinstein D, et al. Neuronal modulation of Schwann cell glial fibrillary acidic protein (GFAP). J Neurosci Res 1989; 23: 396-405.
26. Monaco S, Bonetti B, Ferrari S, Moretto G, Nardelli E, Tedesco F, et al. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N Engl J Med 1990; 322: 649-52.
27. Montag D, Giese KP, Bartsch U, Martini R, Lang Y, Blüthmann H, et al. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 1994; 13: 229-46.
28. Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 1994; 36: 416-24.
29. Ogino M, Tatum AH, Latov N. Affinity studies of human anti-MAG antibodies in neuropathy. J Neuroimmunol 1994; 52: 41-6.
30. Page KM. Histological methods for peripheral nerves - Part I. J Med Lab Technol 1970; 27: 1-17.
31. Poduslo JF. Regulation of myelin gene expression in the peripheral nervous system. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. 3rd ed. Philadelphia: W. B. Saunders, 1993: 282-9.
32. Poltorak M, Sadoul R, Keilhauer G, Landa C, Fahrig T, Schachner M. Myelin-associated glycoprotein, a member of the L2/HNK-1 family of neural cell adhesion molecules, is involved in neuron-oligodendrocyte and oligodendrocyte-oligodendrocyte interaction. J Cell Biol 1987; 105: 1893-9.
33. Schuller-Petrovic S, Gebhart N, Lassmann H, Rumpold H, Kraft D. A shared antigenic determinant between natural killer cells and nervous tissue. Nature 1983; 306: 179-81.
34. Steck AJ, Murray N, Meier C, Page N, Perruisseau G. Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein. Neurology 1983; 33: 19-23.
35. Tatum AH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol 1993; 33: 502-6.
36. Trapp BD. Myelin-associated glycoprotein. Location and potential functions. [Review]. Ann N Y Acad Sci 1990; 605: 29- 43.
37. Trapp BD, Quarles RH. Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin. J Cell Biol 1982; 92: 877-82.
38. Trapp BD, Quarles RH. Immunocytochemical localization of the myelin-associated glycoprotein. Fact or artifact? J Neuroimmunol 1984; 6: 231-49.
39. Trapp BD, Quarles RH, Suzuki K. Immunocytochemical studies of quaking mice support a role for the myelin-associated glycoprotein in forming and maintaining the periaxonal space and periaxonal cytoplasmic collar of myelinating Schwann cells. J Cell Biol 1984; 99: 594-606.
40. Trojaborg W, Galassi G, Hays AP, Lovelace RE, Alkaitis M, Latov N. Electrophysiologic study of experimental demyelination induced by serum of patients with IgM M proteins and neuropathy. Neurology 1989: 39: 1581-6.
41. Umemori H, Sato S, Yagi T, Aizawa S, Yamamoto T. Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 1994; 367: 572-6.
42. Vital C, Vallat J-M. Elementary parenchymal lesions. In: Vital C, Vallat J-M, editors. Ultrastructural study of the human diseased peripheral nerve. New York: Elsevier, 1987: 27-92.
43. Vital A, Vital C, Julien J, Baquey A, Steck AJ. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients. Acta Neuropathol (Berl) 1989; 79: 160-7.
44. Weber K, Shaw G, Osborn M, Debus E, Geisler N. Neurofilaments, a subclass of intermediate filaments: structure and expression. Cold Spring Harb Symp Quant Biol 1983; 48: 717-29.